A recent PhD recipient at the University of Texas at Dallas has been selected by the Howard Hughes Medical Institute for a ...

Positive results from its Phase III STEER study mean Novartis could boost sales of its OAV101 IT drug for spinal muscular ...

Dorsal root ganglion is an entity of its own. Partial rhizotomy of the DRG is not intended to treat axial back pain, deafferantion pain or sympathetically maintained pain, such as complex regional ...

Capsida Biotherapeutics yesterday revealed US pharma major AbbVie has exercised an option for the first neurodegenerative ...

The University of Cincinnati’s Jun-Ming Zhang has received a five-year, $3.1 million grant from the National Institute of ...

I would have been bored, except the pain was so tiring that I could barely function. I spent the days shuffling around the ...

On 30 December 2024, Novartis reported that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) reached ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) ...

We find that, following axotomy, sympathetic neurons in the superior cervical ganglion express vasoactive intestinal peptide (VIP), galanin, and pituitary adenylate cyclase-activating polypeptide, ...